• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

活性状态下 PARP1 的捕获快照揭示了 PARP1 变构的机制。

Captured snapshots of PARP1 in the active state reveal the mechanics of PARP1 allostery.

机构信息

Department of Biochemistry and Molecular Medicine, Université de Montréal, Montréal, QC H3T 1J4, Canada.

CRUK Gene Function Laboratory and Breast Cancer Now Toby Robins Research Centre, Institute of Cancer Research, London SW3 6JB, UK.

出版信息

Mol Cell. 2022 Aug 18;82(16):2939-2951.e5. doi: 10.1016/j.molcel.2022.06.011. Epub 2022 Jul 5.

DOI:10.1016/j.molcel.2022.06.011
PMID:35793673
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9391306/
Abstract

PARP1 rapidly detects DNA strand break damage and allosterically signals break detection to the PARP1 catalytic domain to activate poly(ADP-ribose) production from NAD. PARP1 activation is characterized by dynamic changes in the structure of a regulatory helical domain (HD); yet, there are limited insights into the specific contributions that the HD makes to PARP1 allostery. Here, we have determined crystal structures of PARP1 in isolated active states that display specific HD conformations. These captured snapshots and biochemical analysis illustrate HD contributions to PARP1 multi-domain and high-affinity interaction with DNA damage, provide novel insights into the mechanics of PARP1 allostery, and indicate how HD active conformations correspond to alterations in the catalytic region that reveal the active site to NAD. Our work deepens the understanding of PARP1 catalytic activation, the dynamics of the binding site of PARP inhibitor compounds, and the mechanisms regulating PARP1 retention on DNA damage.

摘要

PARP1 能快速检测 DNA 链断裂损伤,并通过别构方式向 PARP1 催化结构域发出断裂检测信号,从而激活 NAD 来源的聚(ADP-核糖)的产生。PARP1 的激活表现为一个调节螺旋结构域(HD)的结构发生动态变化;然而,对于 HD 对 PARP1 别构的具体贡献,我们的了解非常有限。在这里,我们已经确定了 PARP1 的孤立活性状态的晶体结构,这些结构显示了特定的 HD 构象。这些捕获的快照和生化分析表明,HD 对 PARP1 多结构域和与 DNA 损伤的高亲和力相互作用有贡献,为 PARP1 别构的力学提供了新的见解,并表明 HD 的活性构象如何与催化区域的改变相对应,从而将活性位点暴露给 NAD。我们的工作加深了对 PARP1 催化激活、PARP 抑制剂化合物结合位点动力学以及 PARP1 在 DNA 损伤上保留的调控机制的理解。

相似文献

1
Captured snapshots of PARP1 in the active state reveal the mechanics of PARP1 allostery.活性状态下 PARP1 的捕获快照揭示了 PARP1 变构的机制。
Mol Cell. 2022 Aug 18;82(16):2939-2951.e5. doi: 10.1016/j.molcel.2022.06.011. Epub 2022 Jul 5.
2
Novel modifications of PARP inhibitor veliparib increase PARP1 binding to DNA breaks.聚(ADP-核糖)聚合酶(PARP)抑制剂维利帕尼的新型修饰增强了PARP1与DNA断裂的结合。
Biochem J. 2024 Mar 20;481(6):437-460. doi: 10.1042/BCJ20230406.
3
Structural and biochemical analysis of the PARP1-homology region of PARP4/vault PARP.PARP4/vault PARP 的 PARP1 同源区的结构和生化分析。
Nucleic Acids Res. 2023 Dec 11;51(22):12492-12507. doi: 10.1093/nar/gkad1064.
4
Poly(ADP-ribose) Polymerase (PARP) and PARP Inhibitors: Mechanisms of Action and Role in Cardiovascular Disorders.聚(ADP-核糖)聚合酶(PARP)和 PARP 抑制剂:作用机制及在心血管疾病中的作用。
Cardiovasc Toxicol. 2018 Dec;18(6):493-506. doi: 10.1007/s12012-018-9462-2.
5
HPF1 completes the PARP active site for DNA damage-induced ADP-ribosylation.HPF1 完成了 PARP 活性部位,以促进 DNA 损伤诱导的 ADP-核糖基化。
Nature. 2020 Mar;579(7800):598-602. doi: 10.1038/s41586-020-2013-6. Epub 2020 Feb 6.
6
Clinical PARP inhibitors do not abrogate PARP1 exchange at DNA damage sites in vivo.临床 PARP 抑制剂不能在体内 DNA 损伤部位消除 PARP1 的交换。
Nucleic Acids Res. 2020 Sep 25;48(17):9694-9709. doi: 10.1093/nar/gkaa718.
7
Poly(ADP-ribosyl)ation by PARP1: reaction mechanism and regulatory proteins.聚(ADP-核糖)化由 PARP1 介导:反应机制和调节蛋白。
Nucleic Acids Res. 2019 May 7;47(8):3811-3827. doi: 10.1093/nar/gkz120.
8
PARP1: Structural insights and pharmacological targets for inhibition.聚腺苷二磷酸核糖聚合酶 1:结构见解与抑制的药理学靶点。
DNA Repair (Amst). 2021 Jul;103:103125. doi: 10.1016/j.dnarep.2021.103125. Epub 2021 Apr 14.
9
Mechanistic insight into the role of Poly(ADP-ribosyl)ation in DNA topology modulation and response to DNA damage.聚(ADP-核糖)化在 DNA 拓扑结构调节和 DNA 损伤反应中的作用的机制见解。
Mutagenesis. 2020 Feb 13;35(1):107-118. doi: 10.1093/mutage/gez045.
10
ADP-ribose contributions to genome stability and PARP enzyme trapping on sites of DNA damage; paradigm shifts for a coming-of-age modification.ADP-核糖基对基因组稳定性的贡献和 PARP 酶在 DNA 损伤部位的捕获;一种成熟修饰的范式转变。
J Biol Chem. 2023 Dec;299(12):105397. doi: 10.1016/j.jbc.2023.105397. Epub 2023 Oct 28.

引用本文的文献

1
Molecular Targets for Pharmacotherapy of Head and Neck Squamous Cell Carcinomas.头颈部鳞状细胞癌药物治疗的分子靶点
Curr Issues Mol Biol. 2025 Aug 1;47(8):609. doi: 10.3390/cimb47080609.
2
Crystal structure and mutagenesis of a nucleic acid-binding BRCT domain in human PARP4.人类PARP4中核酸结合BRCT结构域的晶体结构与诱变研究
J Biol Chem. 2025 Jun;301(6):110277. doi: 10.1016/j.jbc.2025.110277. Epub 2025 May 22.
3
Machine learning-based screening and molecular simulations for discovering novel PARP-1 inhibitors targeting DNA repair mechanisms for breast cancer therapy.基于机器学习的筛选和分子模拟,用于发现针对乳腺癌治疗中DNA修复机制的新型PARP-1抑制剂。
Mol Divers. 2025 Feb 3. doi: 10.1007/s11030-025-11119-4.
4
A PARP2 active site helix melts to permit DNA damage-induced enzymatic activation.聚(ADP-核糖)聚合酶2(PARP2)活性位点螺旋解链以允许DNA损伤诱导的酶激活。
Mol Cell. 2025 Mar 6;85(5):865-876.e4. doi: 10.1016/j.molcel.2025.01.004. Epub 2025 Jan 30.
5
Single-molecule analysis of PARP1-G-quadruplex interaction.聚(ADP-核糖)聚合酶1(PARP1)与G-四链体相互作用的单分子分析
bioRxiv. 2025 Jan 8:2025.01.06.631587. doi: 10.1101/2025.01.06.631587.
6
Aminomethylmorpholino Nucleosides as Novel Inhibitors of PARP1 and PARP2: Experimental and Molecular Modeling Analyses of Their Selectivity and Mechanism of Action.氨甲基吗啉代核苷作为PARP1和PARP2的新型抑制剂:其选择性及作用机制的实验与分子模拟分析
Int J Mol Sci. 2024 Nov 22;25(23):12526. doi: 10.3390/ijms252312526.
7
Coupling cellular drug-target engagement to downstream pharmacology with CeTEAM.利用CeTEAM将细胞药物靶点结合与下游药理学联系起来。
Nat Commun. 2024 Dec 6;15(1):10347. doi: 10.1038/s41467-024-54415-7.
8
PARP1 condensates differentially partition DNA repair proteins and enhance DNA ligation.聚(ADP-核糖)聚合酶1凝聚物以不同方式分配DNA修复蛋白并增强DNA连接。
EMBO Rep. 2024 Dec;25(12):5635-5666. doi: 10.1038/s44319-024-00285-5. Epub 2024 Nov 4.
9
A Genetically Encoded Sensor for Real-Time Monitoring of Poly-ADP-Ribosylation Dynamics In Vitro and in Cells.一种用于实时监测体外和细胞内多聚 ADP-核糖基化动态的基因编码传感器。
ACS Sens. 2024 Oct 25;9(10):5246-5252. doi: 10.1021/acssensors.4c01406. Epub 2024 Oct 1.
10
A PARP2-specific active site α-helix melts to permit DNA damage-induced enzymatic activation.一个PARP2特异性活性位点α-螺旋解旋,以允许DNA损伤诱导的酶促激活。
bioRxiv. 2024 May 20:2024.05.20.594972. doi: 10.1101/2024.05.20.594972.

本文引用的文献

1
HPF1 dynamically controls the PARP1/2 balance between initiating and elongating ADP-ribose modifications.HPF1 动态控制 PARP1/2 之间起始和延伸 ADP-ribose 修饰的平衡。
Nat Commun. 2021 Nov 18;12(1):6675. doi: 10.1038/s41467-021-27043-8.
2
Discovery of 5-{4-[(7-Ethyl-6-oxo-5,6-dihydro-1,5-naphthyridin-3-yl)methyl]piperazin-1-yl}--methylpyridine-2-carboxamide (AZD5305): A PARP1-DNA Trapper with High Selectivity for PARP1 over PARP2 and Other PARPs.发现 5-{4-[(7-乙基-6-氧代-5,6-二氢-1,5-萘啶-3-基)甲基]哌嗪-1-基}-2-甲基吡啶-3-羧酰胺(AZD5305):一种对 PARP1 具有高选择性的 PARP1-DNA 捕获剂,对 PARP2 和其他 PARPs 的选择性较高。
J Med Chem. 2021 Oct 14;64(19):14498-14512. doi: 10.1021/acs.jmedchem.1c01012. Epub 2021 Sep 27.
3
ADP-ribosyltransferases, an update on function and nomenclature.ADP-核糖基转移酶:功能和命名法的最新进展。
FEBS J. 2022 Dec;289(23):7399-7410. doi: 10.1111/febs.16142. Epub 2021 Sep 13.
4
Serine-linked PARP1 auto-modification controls PARP inhibitor response.丝氨酸连接的 PARP1 自身修饰控制 PARP 抑制剂的反应。
Nat Commun. 2021 Jul 1;12(1):4055. doi: 10.1038/s41467-021-24361-9.
5
Activation of PARP2/ARTD2 by DNA damage induces conformational changes relieving enzyme autoinhibition.DNA 损伤激活 PARP2/ARTD2 诱导构象变化,解除酶的自动抑制。
Nat Commun. 2021 Jun 9;12(1):3479. doi: 10.1038/s41467-021-23800-x.
6
HPF1 remodels the active site of PARP1 to enable the serine ADP-ribosylation of histones.HPF1 重塑 PARP1 的活性位点,从而使组蛋白丝氨酸发生 ADP-核糖基化。
Nat Commun. 2021 Feb 15;12(1):1028. doi: 10.1038/s41467-021-21302-4.
7
Dynamics of the HD regulatory subdomain of PARP-1; substrate access and allostery in PARP activation and inhibition.聚(ADP-核糖)聚合酶-1(PARP-1)的高清调节亚结构域的动力学;PARP激活和抑制中的底物可及性与变构效应
Nucleic Acids Res. 2021 Feb 26;49(4):2266-2288. doi: 10.1093/nar/gkab020.
8
Poly (ADP-ribose) polymerase-1 as a promising drug target for neurodegenerative diseases.聚(ADP-核糖)聚合酶-1 作为神经退行性疾病有前景的药物靶点。
Life Sci. 2021 Feb 15;267:118975. doi: 10.1016/j.lfs.2020.118975. Epub 2020 Dec 31.
9
Bridging of DNA breaks activates PARP2-HPF1 to modify chromatin.DNA 断裂的桥接激活 PARP2-HPF1 以修饰染色质。
Nature. 2020 Sep;585(7826):609-613. doi: 10.1038/s41586-020-2725-7. Epub 2020 Sep 16.
10
Clinical PARP inhibitors do not abrogate PARP1 exchange at DNA damage sites in vivo.临床 PARP 抑制剂不能在体内 DNA 损伤部位消除 PARP1 的交换。
Nucleic Acids Res. 2020 Sep 25;48(17):9694-9709. doi: 10.1093/nar/gkaa718.